Dr. Sekeres is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1475 NW 12th Ave
Miami, FL 33136Phone+1 305-243-6302Fax+1 305-243-9161
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
- Massachusetts General HospitalResidency, Internal Medicine, 1996 - 1999
- Perelman School of Medicine at the University of PennsylvaniaClass of 1996
Certifications & Licensure
- FL State Medical License 2020 - 2027
- OH State Medical License 2002 - 2022
- MA State Medical License 1998 - 2003
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes Start of enrollment: 2004 Feb 01
- Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder Start of enrollment: 2005 Oct 01
- Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia Start of enrollment: 2006 May 01
- Join now to see all
Publications & Presentations
PubMed
- Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement.Uma Borate, Kelly Pugh, Allyson Waller, Rina Li Welkie, Ying Huang
Blood. 2025-03-27 - Azacitidine and venetoclax for HR-MDS: election results pending.Sangeetha Venugopal, Mikkael A Sekeres
Blood. 2025-03-13 - Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem dup...Richard F Schlenk, Pau Montesinos, Hee-Je Kim, Antonio Romero-Aguilar, Radovan Vrhovac
Haematologica. 2025-03-13
Journal Articles
- Germline Loss of Function SAMD9 and SAMD9L Alterations in Adult Myelodysplastic SyndromesSamuel Li, Mikkael A Sekeres, Jaroslaw P Maciejewski, Rabi Hanna, Blood
- Relative Survival Following Response to 7 + 3 Versus Azacytidine Is Similar in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes: An Analysis of Four SWOG...Sucha Nand, Mikkael A Sekeres, Nature
- Mutational Landscape of myelodysplastic/myeloproliferative Neoplasm – Unclassifiable (MDS/MPN-U)Aziz Nazha, Rami S Komrokji, Andrew Sochacki, Mikkael A Sekeres, Prithviraj Bose, Courtney D DiNardo, Hagop M Kantarjian, Srdan Verstovsek, Sanam Loghavi, Jaroslaw P M..., Blood
- Join now to see all
Abstracts/Posters
- Molecular Characterization of Leukemia Evolving from Paroxysmal Nocturnal HemoglobinuriMikkael A. Sekeres, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- TET2 Loss Accelerates Leukemogenesis By Disrupting Mismatch Repair ProteinsMikkael A. Sekeres, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Can Monosomy 7 be Targeted By Next Generation Cereblon-Modulating Agents?Mikkael A. Sekeres, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Myelodysplastic Syndromes: From Mild-Mannered to Lurking Leukemia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Special Education Session on ASH Clinical Practice Guidelines on Acute Myeloid Leukemia in Older Adults61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Meeting Tips: Giving a Scientific Presentation, Being a Good Discussant and Asking a Question in the Aisle61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Authored Content
- Cancer Patients Often Want ‘One More Round.’ Should Doctors Say No?March 2024
- Watching My Patient Die, RemotelyNovember 2018
- Resolutions of a Cancer DoctorJanuary 2018
Press Mentions
- Is Clonal Cytopenia of Undetermined Significance Distinct from Lower-Risk Myelodysplastic Syndrome?February 6th, 2025
- Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular LymphomaDecember 11th, 2024
- Study Links Smoking to Genetic Mutations in Blood CancerDecember 10th, 2024
- Join now to see all
Grant Support
- A Phase I/II Study Of Clofarabine &Cytoside ArabinosideNational Center For Research Resources2006
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: